已收盘 02-06 16:00:00 美东时间
+0.600
+1.25%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
Citizens analyst Aaron Hecht reiterates American Healthcare REIT (NYSE:AHR) with a Market Outperform and maintains $60 price target.
02-05 21:56
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38
BMO Capital analyst Juan Sanabria initiates coverage on American Healthcare REIT (NYSE:AHR) with a Outperform rating and announces Price Target of $55.
01-29 21:18
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
Truist Securities analyst Michael Lewis maintains American Healthcare REIT (NYSE:AHR) with a Buy and lowers the price target from $53 to $52.
01-20 20:50
Truist Securities analyst Michael Lewis maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $46 to $53.
2025-11-27 02:01
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从6美元升至8美元;HC Wainwright & Co.:维持MediWound"买入"评级,目标价从31美元升至36美元
2025-11-24 11:23
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
2025-11-21 15:50
American Healthcare REIT, Inc. (NYSE: AHR; the "Company") announced today that it has commenced an underwritten public offering of 8,100,000 shares of its common stock on a forward basis in connection with the
2025-11-21 05:03